Colorado crisis services come together
988 Colorado is a service that provides immediate access to mental health, emotional, or substance use support 24/7 via text, chat, or call.
The passing of this legislation means that starting July 1, all who reach out to CCS will be connected to 988 Colorado. This becomes Colorado's main mental health and crisis line.
'Through the consolidation of Colorado's legacy support line, Colorado Crisis Services, into our national 988 framework, we are ensuring that people in need can access services through one easy-to-remember number,' said Gordon Coombes, 988 Colorado's director. '988 Colorado is staffed 24/7 365 by trained specialists who are ready to provide immediate help to the people of Colorado.'
988 Colorado's Enterprise Board, which includes seven volunteer governor-appointed members, will spread awareness for services through media relations, advertising, and community outreach.
'This is a monumental step towards building a comprehensive and accessible behavioral health system across Colorado, increasing access to care for those in need,' said Dannette R. Smith, Colorado Behavioral Health Administration's commissioner.
The change will also affect the Peer Support Line. Previously offered by CCS, the service will now continue through 988 Colorado.
To contact 988 Colorado, call or text 988, or go to its website to live chat. It's confidential, accessible 24/7, and free.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
03-07-2025
- Yahoo
These Foods Will Be Labeled 'Not Recommended for Human Consumption' in Texas
A new law in Texas will require many popular products to have a label warning consumers that it contains ingredients 'not recommended for human consumption.' It targets M&Ms, Doritos, Mountain Dew, and probably at least one of your grocery store guilty pleasures. The law, which was officially signed by Gov. Greg Abbott, requires any food containing one of more than 40 additives to include the label on its packaging by 2027. Here's a closer look at the additives in question, what nutritionists have to say about the MAHA-adjacent legislation, and more. The law aims to align the Lone Star State with the more cautious approach to processed food seen in Europe. There, food additives — like artificial dyes and preservatives — are strictly regulated. The label, which would be found up and down grocery-store aisles, would read: 'WARNING: This product contains an ingredient that is not recommended for human consumption by the appropriate authority in Australia, Canada, the European Union, or the United Kingdom.' The hope is this will nudge manufacturers to strip their items of the additives. These ingredients, which slip through the cracks of a regulatory loophole, have become a priority of the 'Make America Healthy Again' movement. Some major companies — from General Mills to Nestle — have already committed to removing dyes from their products, but the food industry is still pushing back against the law. 'The ingredients used in the U.S. food supply are safe and have been rigorously studied following an objective science- and risk-based evaluation process,' the Consumer Brands Association trade group wrote in a letter to Abbott. 'The labeling requirements of SB 25 mandate inaccurate warning language, create legal risks for brands and drive consumer confusion and higher costs.' The regulation would only apply to food labels 'developed or copyrighted' on or after Jan. 1, 2027 — meaning that companies would only have to include the warning on food labels they've redesigned or updated, like when new ingredients are added, the Washington Post reports. In general, the move to pay closer attention to these ingredients has been applauded by experts, says Kathleen Melanson, a professor of nutrition at the University of Rhode Island. 'Nutrition professionals and other health organizations have been advocating for more scrutiny of food additives for a long time,' she tells us. However, Dr. Melanson and others in her field say they're not quite sure how state legislators came up with their list of 44 ingredients. And there appear to be some discrepancies. The Associated Press reports that three of the additives — partially hydrogenated oils, Red Dye No. 4, and Red Dye No. 3 — have already been restricted in the U.S., and that some of the other ingredients are allowed in Australia, Canada, the E.U., or U.K. A whole range of artificial dyes are included, from Red No. 3 to Yellow No. 5, which have been controversial for some time. That's because they've been linked to hyperactivity and neurobehavioral issues in children and cancer risk. However, the research supporting this is limited, and some of it has only been proven in animals, Dr. Melanson says. There are several preservatives that have been blacklisted, like butylated hydroxytoluene (BHT) and butylated hydroxyanisole (BHA), which prevent fats in food from going bad. Both ingredients have also been linked to cancer — although, again, in studies on animals, not humans — and BHA is being reviewed in the E.U. for its potential to disrupt hormones. Emulsifiers (or chemicals that help water and oil blend), thickeners, and stabilizers also made the list. Some of these compounds, like propylene glycol, have been linked to allergic reactions and could worsen the symptoms of kidney and liver disease. You can see the full list of 44 additives that would get a warning label here. Dr. Melanson sees the focus on additives as a net positive, but she believes that the more important takeaway for consumers is to minimize the amount of ultra-processed foods in their diets. 'Whether or not a food has a certain dye in it, the main focus should be on getting enough fiber, protein, and other nutrients you need from whole foods,' she says. The post These Foods Will Be Labeled 'Not Recommended for Human Consumption' in Texas appeared first on Katie Couric Media.
Axios
24-06-2025
- Axios
Colorado scrambles to keep 988 suicide counselors for LGBTQ+ callers
Colorado is scrambling to find state dollars to preserve a 988 crisis line for LGBTQ callers after the Trump administration decides to discontinue the service July 17. Why it matters: Colorado's 988 mental health line is a major lifeline to connect people experiencing a crisis with a trained professional. What they're saying: "The organization is also actively reviewing how state resources can be utilized to support additional outreach and education efforts to ensure all Coloradans are aware of the continuous, inclusive support available," Gordon Coombes, director of the 988 Colorado Mental Health Line, said in a statement Tuesday. How it works: Right now, LGBTQ individuals can "press 3" to connect with a support line specifically designed for their needs. By the numbers: The 988 line in Colorado was the fourth most-used in 2024 among states with 36.1 calls, texts and chats per 1,000 people, according to new research published in JAMA Network Open. The big picture: Colorado struggled to accommodate all the calls to the 988 line in the first two years after its debut, according to an Axios analysis of 2024 data, falling well below the national average answer rate. Yes, but: A new law that takes effect July 1 will streamline the process and merge the 988 line with the existing Colorado Crisis Services support center created after the 2013 Aurora theater shooting.
Business Wire
21-06-2025
- Business Wire
CCS Presents Four Peer-Reviewed Posters at American Diabetes Association's 85th Scientific Sessions
CHICAGO--(BUSINESS WIRE)-- CCS, a leading provider of clinical solutions and home-delivered medical supplies for those living with chronic conditions, will present four peer-reviewed posters at the American Diabetes Association's (ADA) 85th Scientific Sessions, which will take place June 20–23 in Chicago. These latest poster presentations illustrate CCS's focus on delivering evidence-based approaches to diabetes care management that ensure patients have the education and coaching they need to thrive and cost-effectively stay adherent while managing their chronic condition. "At CCS, we meet patients where they are — with empathy, education, and evidence-based support..." Share The ADA Scientific Sessions is a globally recognized conference dedicated to advancing the field of diabetes. This annual meeting serves as a critical forum for presenting cutting-edge research, innovation, and new evidence-based approaches to diabetes prevention, management, and care. Presentation Highlights from CCS at the ADA Scientific Sessions CCS's clinical strategy and innovation vice president, Coni Dennis, DNP, RN, and NE-BC, will present findings for all four accepted poster presentations at the ADA's 85th Scientific Sessions, and she shared this insight leading into the event: 'At CCS, we meet patients where they are — with empathy, education, and evidence-based support. These poster presentations reflect our commitment to improving health outcomes for people with diabetes by combining data-driven clinical insight with hands-on, compassionate care.' All poster presentations will take place at the conference on Sunday, June 22, from 12:30–1:30 p.m. CT in West Hall F1. The following are the four specific posters that CCS will be presenting: Presentation Title: Evaluating the Impact of Multichannel Diabetes Care Coaching and Education in Patients New to Continuous Glucose Monitoring Abstract Number: 534 Summary: This study, part of an ongoing randomized control trial (RCT), evaluated whether adults with diabetes newly starting a continuous glucose monitor (CGM) achieve better outcomes when they receive diabetes self-management education and support (DSMES) from a certified diabetes care and education specialist (CDCES), compared to using a CGM alone. Presentation Title: Examining the Impact of Continuous Glucose Monitoring Sourcing in Medicaid Patients — Adherence, Healthcare Costs, and Utilization Abstract Number: 1046 Summary: This study compared healthcare costs and utilization among Medicaid beneficiaries who received CGM supplies through a pharmacy or a durable medical equipment provider. Presentation Title: Healthcare Costs and Utilization Among Patients Eligible for Continuous Glucose Monitors — A Comparison of Users and Nonusers Abstract Number: 1049 Summary: This retrospective cohort study used claims data to compare glycemic control, healthcare utilization, and total cost of care over 12 months among individuals on bolus insulin who used CGMs versus those who did not. It also assessed the incidence of hypoglycemia and diabetic ketoacidosis (DKA). Presentation Title: Evaluating an Evidence-Based Quality Improvement Initiative for Food Insecurity Screening and Referral in Adults with Diabetes Initiating Continuous Glucose Monitor Therapy Abstract Number: 1143 Summary: This study assessed food insecurity (FI) among adults with diabetes initiating CGM therapy, comparing rates to national averages and examining glycemic outcomes between food-insecure and food-secure individuals. These posters will be made available on the American Diabetes Association's website after August 25. About CCS CCS is the strategic partner addressing America's most pressing healthcare challenges through intelligent chronic care management, tackling the $412 billion annual diabetes burden and chronic conditions affecting over 133 million Americans. At the core of CCS's differentiated model is LivingConnected®, a human-led, digitally enabled clinical solution. PropheSee™ — an AI-powered predictive model that identifies nonadherence risk and delivers personalized interventions — is an integral part of this solution, creating a first-of-its-kind platform to improve adherence, enhance clinical outcomes, and help prevent costly hospitalizations. By combining data-driven insights with three decades of industry relationships, CCS is the smart choice for health plans, providers, employers, and manufacturers who believe that value-based care starts by keeping patients healthy and delivers benefits like lower cost of care, improved HEDIS scores, and alleviating provider burnout. CCS's approach extends clinical reach while supporting over 200,000 people nationwide with home-delivered medical supplies and pharmaceuticals annually. Recognized as a Great Place to Work® and with numerous peer-reviewed publications validating our care management approach, CCS is more than a trusted supplier — we're a partner in transforming chronic care delivery. To learn more about how CCS is addressing today's healthcare challenges, visit or connect with us on LinkedIn.
